Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors
City of Hope Medical Center
City of Hope Medical Center
National Cancer Institute (NCI)
Sahlgrenska University Hospital
Centre Oscar Lambret
SWOG Cancer Research Network
Queen Mary University of London
Memorial Sloan Kettering Cancer Center
Swiss Cancer Institute
Indiana University
University Health Network, Toronto
St. Olavs Hospital
Heinrich-Heine University, Duesseldorf
Heinrich-Heine University, Duesseldorf
University of Southern California
N.N. Petrov National Medical Research Center of Oncology
Western University, Canada
Swiss Cancer Institute
Tata Memorial Centre
Alliance for Clinical Trials in Oncology
Centre Leon Berard
Haukeland University Hospital
Masonic Cancer Center, University of Minnesota
Daiichi Sankyo
Canadian Cancer Trials Group
Barts & The London NHS Trust
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
Centre Hospitalier Universitaire Dijon
City of Hope Medical Center
Novartis
Alliance for Clinical Trials in Oncology
Gustave Roussy, Cancer Campus, Grand Paris
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
AHS Cancer Control Alberta
Indiana University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Southampton
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC